APA (7th ed.) Citation

Okumura LM, Antunes VD, Aguiar KS, Farias T, Andrzejevski VM, & Funke VM. (2015). Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: Defining the role of social risk factors and non-adherence to treatment. Centro de Investigaciones y Publicaciones Farmaceuticas.

Chicago Style (17th ed.) Citation

Okumura LM, Antunes VD, Aguiar KS, Farias T, Andrzejevski VM, and Funke VM. Tyrosine Kinase Inhibitors in Patients with Chronic Myelogeneous Leukemia: Defining the Role of Social Risk Factors and Non-adherence to Treatment. Centro de Investigaciones y Publicaciones Farmaceuticas, 2015.

MLA (9th ed.) Citation

Okumura LM, et al. Tyrosine Kinase Inhibitors in Patients with Chronic Myelogeneous Leukemia: Defining the Role of Social Risk Factors and Non-adherence to Treatment. Centro de Investigaciones y Publicaciones Farmaceuticas, 2015.